Safe coadministration of raltegravir-based HAART in HIV-infected patients with HCV-cirrhosis receiving triple therapy with telaprevir or boceprevir.

Journal of acquired immune deficiency syndromes (1999)

Volumn 61, Issue 3, 2012, Pages

  Moreno, Ana ^a   Quereda, Carmen ^a   Montes, Marisa ^a   Pérez Elías, María J ^a   Casado, José L ^a   Rodríguez Sagrado, Miguel A ^a   Mateos, María L ^a   Dronda, Fernando ^a   Bárcena, Rafael ^a   Del Campo, Santos ^a   Moreno, Santiago ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 PYRROLIDONE DERIVATIVE; ALPHA INTERFERON; ANTIVIRUS AGENT; DRUG DERIVATIVE; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; INTEGRASE INHIBITOR; MACROGOL DERIVATIVE; N (3 AMINO 1 (CYCLOBUTYLMETHYL) 2,3 DIOXOPROPYL) 3 (2 ((((1,1 DIMETHYLETHYL)AMINO)CARBONYL)AMINO) 3,3 DIMETHYL 1 OXOBUTYL) 6,6 DIMETHYL 3 AZABICYCLO(3.1.0)HEXAN 2 CARBOXAMIDE; N-(3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL)-3-(2-((((1,1-DIMETHYLETHYL)AMINO)CARBONYL)AMINO)-3,3-DIMETHYL-1-OXOBUTYL)-6,6-DIMETHYL-3-AZABICYCLO(3.1.0)HEXAN-2-CARBOXAMIDE; OLIGOPEPTIDE; PEGINTERFERON ALPHA2A; PROLINE; RALTEGRAVIR; RECOMBINANT PROTEIN; RIBAVIRIN; TELAPREVIR;

CLINICAL TRIAL; DRUG COMBINATION; FEMALE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LIVER CIRRHOSIS; MALE; METHODOLOGY; MIDDLE AGED; MIXED INFECTION; VIROLOGY;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; COINFECTION; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C; HIV INFECTIONS; HIV INTEGRASE INHIBITORS; HIV PROTEASE INHIBITORS; HUMANS; INTERFERON-ALPHA; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OLIGOPEPTIDES; POLYETHYLENE GLYCOLS; PROLINE; PYRROLIDINONES; RECOMBINANT PROTEINS; RIBAVIRIN;

MLCS; MLOWN;

EID: 84872009963     PISSN: None     EISSN: 19447884     Source Type: Journal    
DOI: 10.1097/qai.0b013e31826cc275     Document Type: Letter

References (0)